Table 1 Clinical studies of ICG tracing of gastrointestinal tumours
Year | Tumour type | Sample size | T stage | Tumour diameter (mm) | Concentration (g/L) | Injection site | Mean SLN | Sensitivity (%) |
|---|---|---|---|---|---|---|---|---|
2004 (Nimura et al. 2004) | GC | 84 | T1–T2 | NA | 5 | SS | 10.5 | 100 |
2006 (Nagata et al. 2006) | CRC | 48 | T1–T3 | NA | 5 | SS | 3.5 | 53.6 |
2007 (Ohdaira et al. 2007) | GC | 52 | T1 | NA | 5 | SS | NA | 100 |
2007 (Ishikawa et al. 2007) | GC | 16 | T1–T2 | 21 | 5 | SS | 2.9 | 50 |
2008 (Kusano et al. 2008) | CRC | 26 | T1–T3 | NA | 5 | SM | 2.6 | 33.3 |
2008 (Kusano et al. 2008) | GC | 22 | T1–T3 | NA | 5 | SM | 3.6 | 40 |
2008 (Noura et al. 2008) | CRC | 25 | T2–T3 | 58 | 5 | SM | 3 | 100 |
2008 (Noura et al. 2008) | CRC | 25 | T2–T3 | 58 | 5 | SM | 3 | 100 |
2009 (Ohdaira et al. 2009) | GC | 30 | T1–T2 | 42.6 | 5 | SS | 4.8 | 100 |
2009 (Tajima et al. 2009) | GC | 30 | T1–T3 | NA | 5 | SS | 7.2 | 64.7 |
2010 (Noura et al. 2010a) | CRC | 25 | T1–T3 | 45 | 5 | SM | 3 | 100 |
2010 (Kelder et al. 2010) | GC | 212 | T1 | 30 | 5 | SS | 6 | 97 |
2010 (Tajima et al. 2010) | GC | 38 | T1–T2 | 33.8 | 5 | NA | 7.9 | 75 |
2011 (Hutteman et al. 2010) | CRC | 24 | T1–T4 | 40 | NA | SS/SM | 3 | NA |
2011 (Miyashiro et al. 2011) | GC | 10 | T1 | NA | NA | NA | 3 | 100 |
2012 (Hirche et al. 2011) | CRC | 26 | T1–T4 | NA | 5 | SS | 1.7 | 82 |
2012 (Cahill et al. 2012) | CRC | 18 | T1–T3 | NA | NA | SM | 4.1 | 100 |
2012 (Yano et al. 2012) | GC | 130 | T1–T2 | NA | 0.5 | SS | NA | 100 |
2013 (Pas et al. 2013) | CRC | 14 | T2–T3 | 45 | 2.5 | SS | 4 | NA |
2013 (Schaafsma et al. 2013) | CRC | 22 | T1–T4 | 37 | NA | SM | 3.5 | NA |
2016 (Tummers et al. 2016) | GC | 22 | T1–T4 | 35 | 0.031 | SM | 3.1 | 75 |
2016 (Kinami et al. 2016) | GC | 72 | T1–T3 | 27.6 | 0.05 | SS | 6 | 90.9 |
2016 (Takahashi et al. 2016) | GC | 36 | T1–T2 | NA | 5 | SS | 9.2 | 100 |
2016 (Liberale et al. 2016) | CRC | 20 | Tis, T1–T4 | 39 | 0.5 | SS | 7 | 57 |
2017 (Watanabe et al. 2016) | CRC | 31 | NA | NA | 2.5 | SM | NA | NA |
2017 (Takahashi et al. 2017) | GC | 44 | T1 | 24.8 | 5 | SS | 7.9 | 100 |
2017 (Andersen et al. 2017) | CRC | 29 | T1–T4 | NA | 2.5 | SS | 1.8 | 33 |
2017 (Currie et al. 2017) | CRC | 30 | T1–T4 | 37 | 5 | SM | 3 | 33 |
2017 (Weixler et al. 2017) | CRC | 50 | T1–T4 | NA | 0.5 | SS | 4.4 | 64 |
2018 (Shida et al. 2018) | GC | 60 | T1 | 23 | NA | SS | 5 | 100 |
2018 (Okubo et al. 2018) | GC | 17 | T1–T2 | 19.6 | NA | SS | 4.5 | 100 |
2019 (Kim et al. 2019) | GC | 28 | T1 | 16 | NA | SS | NA | 100 |